LAKE OSWEGO, Ore., June 7, 2017 /PRNewswire/ — BIOTRONIK today announced the availability of the Edora line of devices, the company’s first available pacemaker series featuring BIOTRONIK’s MRI AutoDetect technology. Edora SR-T is the smallest MR conditional pacemaker with automated MRI detection capability available in the US with a volume of […]
Author: Ken Dropiewski
InspireMD Announces Distribution Agreement For CGuard EPS In Poland
TEL AVIV, ISRAEL–(Marketwired – June 05, 2017) – InspireMD, Inc. (NYSE MKT: NSPR) (NYSE MKT: NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced it has signed an agreement with Arteriae Sp. z o.o. sp.k, a leading medical […]
Europe’s LimFlow Hires a COO and Opens Bay Area Office
LimFlow Expands Senior Management Team And Opens Silicon Valley Office PARIS–(BUSINESS WIRE)–LimFlow SA, developer of minimally-invasive technology for the treatment of end-stage critical limb ischemia (CLI), a severe form of peripheral artery disease (PAD), today announced the expansion of the company’s senior management team. Sophie Humbert, PhD, has been appointed […]
HeartFlow Names Healthcare Industry Veteran Michael Buck as Executive Vice President and Chief Commercial Officer
REDWOOD CITY, Calif.–(BUSINESS WIRE)–HeartFlow Inc. has announced the appointment of seasoned healthcare leader Michael Buck as executive vice president and chief commercial officer. Effective immediately, Buck will be responsible for expanding and accelerating global market adoption of the company’s HeartFlow® FFRct Analysis, the first noninvasive technology to provide insight into […]
Will iFR and OCT be the New Gold Standard for Pre-Intervention Analysis?
By Ken Dropiewski A new technique may soon bring even more precision to interventional cardiology. Patients with known coronary lesions are being urged to undergo two additional tests before intervention. These diagnostic tools are Instant Wave-free ratio (iFR) and Optical Coherence Tomography (OCT), and they help cardiologist make important decisions […]
SecurAcath Receives NICE Recommendation: Highlights Massive Cost Savings from Improved Catheter Securement
PLYMOUTH, Minn.–(BUSINESS WIRE)–Interrad Medical, a privately held medical device company, announces the SecurAcath Subcutaneous Engineered Stabilization Device is now recommended by the National Institute for Health and Care Excellence (NICE). The SecurAcath underwent a detailed assessment under the Medical Technologies Evaluation Program. As a result, NICE has published guidance supporting […]
Cagent Vascular Completes Enrollment of PRELUDE Study Using Serranator Device
WAYNE, Pa.–(BUSINESS WIRE)–Cagent Vascular, a developer of next generation technology for vessel dilatation in cardiovascular disease interventions, including the FDA 510(k) cleared Serranator® Alto PTA Serration Balloon Catheter, announces the completion of enrollment in the First-in-Human PRELUDE Study. The purpose of this prospective, single-arm, multicenter feasibility study is to show […]
OrbusNeich Announces FDA Clearance, Launch of Coronary Dilatation Catheters
HONG KONG, June 6, 2017 /PRNewswire/ — Announcement marks company‘s official entry into the US market OrbusNeich, a global company specializing in the provision of life-changing vascular solutions, has announced the launch of its world-renowned Sapphire PTCA balloon dilatation catheters following their recent 510k clearance by the FDA: the Sapphire™ […]
Avera Names Myles Greenberg, MD, as CEO of Alucent Medical
SIOUX FALLS, S.D.–(BUSINESS WIRE)–Myles D. Greenberg, MD, was named President and CEO of Alucent Medical, Inc., a new company licensed to develop a novel drug/device combination therapy for the treatment of peripheral vascular disease (PVD). The treatment, Natural Vascular Scaffolding (NVS)TM, has recently gained FDA approval to move forward with […]
Edwards SAPIEN 3 Valve Receives FDA Approval For Aortic, Mitral Valve-In-Valve Procedures
IRVINE, Calif., June 5, 2017 — Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced it has received U.S. Food and Drug Administration (FDA) approval for aortic and mitral valve-in-valve procedures using the Edwards SAPIEN 3 transcatheter heart valve. […]



